Empowering cell therapy with proteomics and more
In cell therapy, disease is treated or prevented by the administration of unmodified or modified cells. These cells can be derived from the patient (autologous) or from another donor (allogeneic). This modality has transformative potential for the treatment of a wide range of diseases and is currently used to treat hematological malignancies and other cancers, among other indications. At Momentum, we support the generation of novel cell therapies by providing high-quality research services that address critical aspects of the discovery and development process.






